Department of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong, P.R. China.
J Neurochem. 2019 Jun;149(6):729-746. doi: 10.1111/jnc.14703. Epub 2019 May 8.
Sphingosine-1-phosphate (S1P) is an essential bioactive sphingosine lipid involved in many neurological disorders. Sphingosine kinase 1 (SphK1), a key enzyme for S1P production, is concentrated in presynaptic terminals. However, the role of S1P/SphK1 signaling in exocytosis remains elusive. By detecting catecholamine release from single vesicles in chromaffin cells, we show that a dominant negative SphK1 (SphK1 ) reduces the number of amperometric spikes and increases the duration of foot, which reflects release through a fusion pore, implying critical roles for S1P in regulating the rate of exocytosis and fusion pore expansion. Similar phenotypes were observed in chromaffin cells obtained from SphK1 knockout mice compared to those from wild-type mice. In addition, extracellular S1P treatment increased the number of amperometric spikes, and this increase, in turn, was inhibited by a selective S1P3 receptor blocker, suggesting extracellular S1P may regulate the rate of exocytosis via activation of S1P3. Furthermore, intracellular S1P application induced a decrease in foot duration of amperometric spikes in control cells, indicating intracellular S1P may regulate fusion pore expansion during exocytosis. Taken together, our study represents the first demonstration that S1P regulates exocytosis through distinct mechanisms: extracellular S1P may modulate the rate of exocytosis via activation of S1P receptors while intracellular S1P may directly control fusion pore expansion during exocytosis. OPEN SCIENCE BADGES: This article has received a badge for Open Materials because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
鞘氨醇-1-磷酸(S1P)是一种参与许多神经疾病的必需生物活性鞘氨醇脂质。鞘氨醇激酶 1(SphK1)是 S1P 产生的关键酶,集中在突触前末梢。然而,S1P/SphK1 信号在胞吐作用中的作用仍不清楚。通过检测嗜铬细胞中单囊泡中儿茶酚胺的释放,我们发现显性失活的 SphK1(SphK1)减少了电流峰的数量并增加了峰的尾部,这反映了通过融合孔的释放,表明 S1P 在调节胞吐作用的速率和融合孔扩张中起关键作用。与野生型小鼠相比,从 SphK1 敲除小鼠获得的嗜铬细胞中观察到类似的表型。此外,细胞外 S1P 处理增加了电流峰的数量,而这种增加又被选择性的 S1P3 受体阻滞剂抑制,表明细胞外 S1P 可能通过激活 S1P3 来调节胞吐作用的速率。此外,细胞内 S1P 应用导致对照细胞中电流峰尾部的持续时间减少,表明细胞内 S1P 可能在胞吐作用过程中调节融合孔的扩张。总之,我们的研究首次表明 S1P 通过不同的机制调节胞吐作用:细胞外 S1P 可能通过激活 S1P 受体来调节胞吐作用的速率,而细胞内 S1P 可能在胞吐作用过程中直接控制融合孔的扩张。